STOMACH NEOPLASMS
Clinical trials for STOMACH NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new STOMACH NEOPLASMS trials appear
Sign up with your email to follow new studies for STOMACH NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise against stomach cancer
Disease control CompletedThis large Phase 3 trial tested adding the immunotherapy drug pembrolizumab (Keytruda) to standard chemotherapy for people with advanced stomach cancer that cannot be removed by surgery. Over 1,500 participants received either pembrolizumab plus chemo or a placebo plus chemo. The…
Matched conditions: STOMACH NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Real-World check: does adding nivolumab to chemo help stomach cancer patients?
Knowledge-focused CompletedThis study looked at how well a combination of nivolumab (an immunotherapy drug) and chemotherapy works for people with advanced or recurrent stomach cancer who haven't had treatment before. It involved 500 patients in Japan and tracked things like how long the cancer stayed unde…
Matched conditions: STOMACH NEOPLASMS
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Massive study digs into genetic roots of stomach cancer
Knowledge-focused CompletedThis study collected information from 733 people with a personal or family history of hereditary stomach cancer. The goal was to better understand how these cancers develop and what genes are involved. Participants provided medical history, blood samples, and genetic testing. The…
Matched conditions: STOMACH NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC